Elekta

Elekta is a global medical technology company founded in 1972 by neurosurgeon Lars Leksell and his son Laurent Leksell. The company focuses on advancing cancer care and treating brain disorders. It is known for the Leksell Gamma Knife, a noninvasive radiosurgery device that revolutionized the treatment of brain cancer and other neurological conditions. Elekta's core offerings include precision radiation therapy and radiosurgery solutions. Its flagship product, the Gamma Knife, uses focused gamma radiation for noninvasive treatment of brain tumors. The company also provides linear accelerators for radiotherapy, advanced multi-leaf collimators, and brachytherapy solutions. Elekta collaborates with healthcare providers worldwide to enhance patient outcomes through its innovative technologies. With a strong presence in key markets such as the United States, Japan, China, and Europe, Elekta employs over 4,500 people globally. Its technologies are utilized by hospitals and cancer treatment centers, aiming to improve survival rates and quality of life for patients with cancer and brain disorders.

• Employees 4600
• Founded 1972
• Annual Revenue $1869298000
• Total Funding $233200000